Long-term effects of supervised exercise training on walking capacity and quality of life in patients with intermittent claudication

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 3, 2008, Pages 250-256

  Keo, Hong H ^a   Grob, E ^a   Guggisberg, F ^a   Widmer, J ^a   Baumgartner, I ^a   Schmid, J P ^a   Kalka, C ^a   Saner, H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Exercise; Long term results; Peripheral arterial disease; Treadmill; Walking capacity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; SMOKING CESSATION; THERAPY EFFECT; WALKING; CLINICAL TRIAL; CONVALESCENCE; EXERCISE TEST; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; SMOKING; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOVERY OF FUNCTION; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 63049122861     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.3.250     Document Type: Article

References (27)

1. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS. Compendium of Physical Activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-504.
2. Barletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Brevetti G. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996; 1: 3-7.
3. Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006; 19: CD005263.
4. Bernstein M, Sloutskis D, Kumanyika S, Sparti A, Schutz Y, Morabia A. Data-based approach for developing a physical activity frequency questionnaire. American Journal of Epidemiology 1998; 147: 147-54.
5. Bullinger M, Cachovan M, Creutzig A, Diehm C, Gruss J, Heidrich H, Kirchberger I, Loeprecht H, Rogatti W. [Entwicklung eines krankheitsspezifischen Instruments zur Erfassung der Lebensqualität von Patienten mit arterieller Verschlusskrankheit (PAVK-86 Fragebogen)]. VASA 1996; 25: 32-40.
6. Chetter IC, Dolan P, Spark JI, Scott DJ, Kester RC. Correlating clinical indicators of lower-limb ischaemia with quality of life. Cardiovasc Surg 1997; 5: 361-6.
7. Criqui MH. Peripheral arterial disease-epidemiological aspects. Vasc Med 2001; 6: 3-7.
8. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. The Chicago Claudication Outcomes Research Group. J Vasc Surg 1996; 24: 503-11.
9. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg 2005; 42: 702-9.
10. Heidrich H, Bullinger M, Cachovan M, Creutzig A, Diehm C, Gruss JD, Kirchberger I, Loeprecht H, Rogatti W. Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire. Med Klin 1995; 90: 693-7.
11. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91: 1472-9.
12. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286: 1317-24.
13. Liu Y, Lormes W, Baur C, Opitz-Gress A, Altenburg D, Lehmann M, Steinacker JM. Human skeletal muscle HSP70 response to physical training depends on exercise intensity. Int J Sports Med 2000; 21: 351-5.
14. McDermott MM, Liu K, Ferrucci L, Criqui MH, Greenland P, Guralnik JM, Tian L, Schneider JR, Pearce WH, Tan J, Martin GJ. Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med 2006; 144: 10-20.
15. Menard JR, Smith HE, Riebe D, Braun CM, Blissmer B, Patterson RB. Long-term results of peripheral arterial disease rehabilitation. J Vasc Surg 2004; 39: 1186-92.
16. Müller-Bühl U, Kirchberger I, Wiesemann A. Relevance of claudication pain distance in patients with peripheral arterial occlusive disease. VASA 1999; 28: 24-8.
17. Nehler MR, Hiatt WR. Exercise therapy for claudication. Ann Vasc Surg 1999; 13: 109-14.
18. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II 2007). J Vasc Surg 2007; 45: 5-67.
19. Pandian G, Hamid F, Hammond MC. Rehabilitation of the patient with peripheral vascular disease and diabetic foot problems. Rehabilitation Medicine: Principles and Practice. Third Edition, edited by DeLisa JA and Gans BM, Lippincott-Raven Publishers. Philadelphia 1998; pp. 1517-44.
20. Quick CR, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982; 69: 24-6.
21. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997; 48: 291-300.
22. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996; 23: 104-15.
23. Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med 1997; 2: 286-91.
24. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941-51.
25. Taft C, Karlsson J, Gelin J, Jivegard L, Sandström R, Arvidsson B, Dahllöf AG, Lundholm K, Sullivan M. Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: One-year results of health-related quality of life. Eur J Vasc Endovasc Surg 2001; 22: 114-23.
26. Treat-Jacobson D, Halverson SL, Ratchford A, Regensteiner JG, Lindquist R, Hirsch AT. A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh 2002; 34: 55-60.
27. Williams LR, Ekers MA, Collins PS, Lee JF. Vascular rehabilitation: benefits of a structured exercise/risk modification program. J Vasc Surg 1991; 14: 320-6.